Ledger.Open graph →

SEC Form D · filed March 11, 2016

PLX PHARMA INC

Offering

$2.0M

Sold

$1.3M

Exemption

Rule 506(b)

Industry

Pharmaceuticals

Location

HOUSTON, TX

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (25)

Natasha J. Giordano · Houston, TXExec · Director David J. Jorden · Houston, TXExec Gary J. Balkema · Houston, TXDirector Gary J. Mossman · Houston, TXExec Kirk J. Calhoun · Houston, TXDirector Michael J. Valentino · Houston, TXDirector Bob Casale · Houston, TXDirector John Hadden Ii · Houston, TXDirector Davie Fedel · Henderson, NVExec Michael Martin · New York, NYDirector Jennifer S. Strickland · Austin, TXDirector Daniel P. Howell · Chicago, ILExec Frederic L. Puzin · PARIS, I0Director Upendra Marathi · Houston, TXExec Ron Zimmerman · Houston, TXExec Wayne Jones · Henderson, NVDirector George W. Pasha, Iv · San Rafael, CADirector Marc E. Sacks · Chicago, ILExec Mark Deutschmann · Nashville, TNExec · Director Kevin Clark · Springdale, ARDirector Jacob Huff · Louisville, KYExec · Director Upendra Marathi · Houston, TXExec Bob Casale · Houston, TXDirector Ron Zimmerman · Houston, TXExec John Hadden Ii · Houston, TXDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗